Literature DB >> 10232568

Outcome of kidney transplantation from high-risk donors is determined by both structure and function.

J Karpinski1, G Lajoie, D Cattran, S Fenton, J Zaltzman, C Cardella, E Cole.   

Abstract

METHOD: Despite the need to expand the donor pool, it is unclear what parameters should be used. The value of donor renal pathology and calculated creatinine clearance (CrCl) in determining recipient outcome was assessed in 57 kidney transplants from 34 donors in whom pretransplant renal biopsies were performed because of age > or =60, hypertension, and/or vascular disease. We retrospectively compared clinical outcomes in these recipients and 57 control recipients selected to have the same baseline demographics but receiving transplants from low risk donors who were significantly younger (32+/-13.9 vs. 61+/-7.3 years) and lighter weight (71+/-18.1 vs. 84+/-20.2 kg) than the high-risk donors (P<.001 for both).
RESULTS: Recipients of high-risk kidneys had a higher incidence of delayed graft function, defined by a <10% fall in serum creatinine (Cr) in the first 24 hr, (56% vs. 30%, P<.01), a higher incidence of rejection (60% vs. 37%, P = .02) and a higher Cr level (197+/-64 vs. 144+/-54 micromol/L at 18 months, P<.005). Graft and patient survival were similar; 12% and 5% vs. 91% and 9% in high-risk vs. control groups, respectively (P = NS). Donor renal pathology was scored 0-3 (none to severe disease) in four areas: glomerulosclerosis, interstitial fibrosis, tubular atrophy, and vascular disease. A donor vessel score of 3/3 was associated with a 100% incidence of delayed graft function and a mean 1-year Cr level of 275+106 micromol/L (compared with 43% and 192+54 micromol/L in those with lower vessel scores, P<.05). Calculated donor CrCl <100 ml/min was associated with higher recipient Cr levels at 1 year, 240+/-95 micromol/L vs. 180+/-54 micromol/L in recipients of kidneys from donors with CrCl levels >100 ml/min (P<.05). The mean 1-year Cr level was 320+/-102 micromol/L in recipients with both a vascular score of 3/3 and a donor CrCl <100 ml/min and 184+/-63 micromol/L in those with neither factor (P = .001).
CONCLUSION: Calculated donor CrCl and donor vascular pathology predict recipient graft function and may be helpful in selecting high-risk donors for single kidney transplantation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10232568     DOI: 10.1097/00007890-199904270-00013

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  31 in total

Review 1.  Assessment of kidney organ quality and prediction of outcome at time of transplantation.

Authors:  Thomas F Mueller; Kim Solez; Valeria Mas
Journal:  Semin Immunopathol       Date:  2011-01-28       Impact factor: 9.623

2.  Single centre experience of hypothermic machine perfusion of kidneys from extended criteria deceased heart-beating donors: a comparative study.

Authors:  J C Forde; W P Shields; M Azhar; P J Daly; J A Zimmermann; G P Smyth; M P Eng; R E Power; P Mohan; D P Hickey; D M Little
Journal:  Ir J Med Sci       Date:  2014-12-05       Impact factor: 1.568

Review 3.  German recommendations for pretransplantation donor kidney biopsies.

Authors:  Przemyslav Pisarski; Christina Schleicher; Ingeborg Hauser; Jan U Becker
Journal:  Langenbecks Arch Surg       Date:  2016-03-19       Impact factor: 3.445

4.  Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneys.

Authors:  Ilaria Girolami; Giovanni Gambaro; Claudio Ghimenton; Serena Beccari; Anna Caliò; Matteo Brunelli; Luca Novelli; Ugo Boggi; Daniela Campani; Gianluigi Zaza; Luigino Boschiero; José Ignacio López; Guido Martignoni; Antonia D'Errico; Dorry Segev; Desley Neil; Albino Eccher
Journal:  J Nephrol       Date:  2019-08-30       Impact factor: 3.902

Review 5.  Delayed graft function in the kidney transplant.

Authors:  A Siedlecki; W Irish; D C Brennan
Journal:  Am J Transplant       Date:  2011-09-19       Impact factor: 8.086

6.  Histological Evidence of Diabetic Kidney Disease Precede Clinical Diagnosis.

Authors:  Giorgia Comai; Deborah Malvi; Andrea Angeletti; Francesco Vasuri; Sabrina Valente; Francesca Ambrosi; Irene Capelli; Matteo Ravaioli; Gianandrea Pasquinelli; Antonietta D'Errico; Alessia Fornoni; Gaetano La Manna
Journal:  Am J Nephrol       Date:  2019-06-05       Impact factor: 3.754

7.  Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant.

Authors:  Robert J Stratta; Michael S Rohr; Aimee K Sundberg; Greg Armstrong; Gloria Hairston; Erica Hartmann; Alan C Farney; Julie Roskopf; Samy S Iskandar; Patricia L Adams
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

8.  Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney Transplantation.

Authors:  Tarek Alhamad; Daniel C Brennan; Zaid Brifkani; Huiling Xiao; Mark A Schnitzler; Vikas R Dharnidharka; David Axelrod; Dorry L Segev; Krista L Lentine
Journal:  Transplantation       Date:  2016-05       Impact factor: 4.939

9.  Use of two expanded-criteria-donor renal allografts in a single patient.

Authors:  Edmund Q Sanchez; Bernard V Fischbach; Gomathy Narasimhan; Srinath Chinnakotla; Dmitriy Nikitin; Tariq Khan; Henry B Randall; Gregory J McKenna; Richard Ruiz; Robert M Goldstein; Göran B Klintmalm; Marlon F Levy
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-07

10.  Marginal kidney donor.

Authors:  Ganesh Gopalakrishnan; Siva Prasad Gourabathini
Journal:  Indian J Urol       Date:  2007-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.